Supply for acetaminophen with codeine, such as Tylenol 3, has improved, but shortages of acetaminophen with oxycodone, like ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while supply of ...

Shortages of some prescription painkillers are expected to continue for a few months in Canada. In July, Health Canada announced a shortage of drugs that contain acetaminophen with oxycodone, ...

Canadian pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while ...

Manufacturer has indicated some supply will be available in December, though there will be constraints because of backorders ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

Pharmacists say a shortage of some prescription painkillers is expected to continue as alternatives have seen an increase ...

Kenvue is under scrutiny after the Trump administration linked Tylenol to autism. Merger aims for $32 billion in annual revenue and $7 billion operating profit. The deal is expected to close in the ...

The health secretary doubled down on his assertion that the over-the-counter pain reliever is problematic, noting, "We’re doing the studies to make the proof.” His claims are resonating with ...

Kenvue, the American company that makes Tylenol, says the U.S. Food and Drug Administration should not make proposed changes to the product’s safety label to reflect research about a possible ...